Stock Monthly: Antibe Therapeutics (ATE:70.0c) soars 15%, 2 months' volume in a month Thursday April 30, 2020 17:00 EDT
Apr 30, 2020 - News Bites Canadian Markets
Board and Executive Moves-Financial Results
CANADIAN MONTHLY STOCK REPORT
Antibe Therapeutics (TSXV:ATE), Canada's 7th largest Biotechnology company by market cap, has soared 9.0c (or 14.8%) in the past month to close at 70.0c on Thursday April 30. The volume was 2 times average monthly trading of 22 million shares. Compared with the S&P/TSX 60 Index which rose 71.7 points (or 8.8%) in the month, this represented a relative price increase of 6%. In the past month the market cap has jumped CAD26.5 million (US$36.7 million).
Price Change % 1-month 6-month 3-year ATE 14.8% 37.3% 311.8% Biotechnology sector 10.2% 6.7% 71.8% S&P/TSX 60 Index 8.8% -9.6...
Sign up today to gain access to 5 free articles a month from over 200 top subscription outlets.
Are you ready to take your business development to the next level with RelSci Professional?
Nurture your network with daily alerts that notify you when your relationships make news
Map your relationships to any target or prospect to identify a warm introduction
Access unlimited deep dossiers on over 8 million decision makers
Best of all, you can try out all these powerful business development tools absolutely free for 30 days!
Check out News Home to stay on top of the people and organizations you care most about.
